Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.

by Kihyuck Kwak, Rosie Jiang, Joshua W Wang, Subhashini Jagu, Reinhard Kirnbauer, Richard B S Roden
Published 2014-01-01

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

by Kihyuck Kwak, Rosie Jiang, Subhashini Jagu, Joshua W Wang, Chenguang Wang, Neil D Christensen, Richard B S Roden
Published 2013-01-01

Optimization of multimeric human papillomavirus L2 vaccines.

by Subhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, Warner K Huh, Vijayarangam Damotharan, Sudha V Chivukula, Richard B S Roden
Published 2013-01-01

Capsomer vaccines protect mice from vaginal challenge with human papillomavirus.

by Wai-Hong Wu, Elizabeth Gersch, Kihyuck Kwak, Subhashini Jagu, Balasubramanyam Karanam, Warner K Huh, Robert L Garcea, Richard B S Roden
Published 2011-01-01

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.

by Joshua W Wang, Subhashini Jagu, Chenguang Wang, Henry C Kitchener, Sai Daayana, Peter L Stern, Susana Pang, Patricia M Day, Warner K Huh, Richard B S Roden
Published 2014-01-01